Reply: A morpho-molecular prognostic model for hepatocellular carcinoma

Por Srivastava, S, Salto-Tellez, M
Publicado em 2013

Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications

Por Kong, S L, Salto-Tellez, M, Leong, A P K, Chan, Y H, Koay, E S C
Publicado em 2005

Interobserver variation in cell selection for DNA image cytometry.

Por Carey, F A, Gray, E, Salto-Tellez, M, Kelly, C, Dye, R, Duvall, E, Lamb, D
Publicado em 1995

Lymphocytic gastritis-like T cell lymphoma: molecular evidence of an unusual recurrence

Por Nga, M E, Tan, S H, Teh, M, Koay, E S C, Chong, S M, Putti, T C, Salto-Tellez, M
Publicado em 2004

A morpho-molecular prognostic model for hepatocellular carcinoma

Por Srivastava, S, Wong, K F, Ong, C W, Huak, C Y, Yeoh, K G, Teh, M, Luk, J M, Salto-Tellez, M
Publicado em 2012

The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome

Por Soong, R, Shah, N, Peh, B K, Chong, P Y, Ng, S S, Zeps, N, Joseph, D, Salto-Tellez, M, Iacopetta, B, Ito, Y
Publicado em 2009

Sequential expression of putative stem cell markers in gastric carcinogenesis

Por Wang, T, Ong, C W, Shi, J, Srivastava, S, Yan, B, Cheng, C L, Yong, W P, Chan, S L, Yeoh, K G, Iacopetta, B, Salto-Tellez, M
Publicado em 2011

Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours

Por Salto-Tellez, M, Nga, M E, Han, H C, Wong, A S-C, Lee, C K, Anuar, D, Ng, S S, Ho, M, Wee, A, Chan, Y H, Soong, R
Publicado em 2007

Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancer

Por Turkington, R C, Longley, D B, Allen, W L, Stevenson, L, McLaughlin, K, Dunne, P D, Blayney, J K, Salto-Tellez, M, Van Schaeybroeck, S, Johnston, P G
Publicado em 2014

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or withou...

Por Soong, R., Shah, N., Salto-Tellez, M., Tai, B. C., Soo, R. A., Han, H. C., Ng, S. S., Tan, W. L., Zeps, N., Joseph, D., Diasio, R. B., Iacopetta, B.
Publicado em 2008

RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC

Por Selvarajan, V, Osato, M, Nah, G S S, Yan, J, Chung, T-H, Voon, D C-C, Ito, Y, Ham, M F, Salto-Tellez, M, Shimizu, N, Choo, S-N, Fan, S, Chng, W-J, Ng, S-B
Publicado no Leukemia (2017)

Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer

Por Riley, J S, Hutchinson, R, McArt, D G, Crawford, N, Holohan, C, Paul, I, Van Schaeybroeck, S, Salto-Tellez, M, Johnston, P G, Fennell, D A, Gately, K, O'Byrne, K, Cummins, R, Kay, E, Hamilton, P, Stasik, I, Longley, D B
Publicado em 2013

P04.46 Variable RNA sequencing depth impacts gene signatures and target compound robustness - case study examining brain tumour (glioma) disease progression

Por Stupnikov, A, McInerney, C E, O’Reilly, P G, Roddy, A C, Dunne, P D, Gilmore, A, Savage, K, McIntosh, S A, Flannery, T, Healy, E, Ellis, H P, Kurian, K M, Emmert-Streib, F, Prise, K M, Salto-Tellez, M, McArt, D G
Publicado no Neuro Oncol (2018)